By Amy Ritter.
In the wake of the meningitis outbreak caused by contaminated compounded medications produced by the New England Compounding Center (NECC), both the government and the public have been wrestling with the question of how this happened — how did a company producing substandard medicines slip through regulatory oversight?
PharmExec Blog
Follow Us
RSS
Bookstore
FDA Already Knew of Problems at New England Compounding Center